Results 61 to 70 of about 33,815 (233)

Chronic beta-adrenoceptor blockade and human atrial cell electrophysiology: evidence of pharmacological remodelling [PDF]

, 2003
<b>Objective:</b> Chronic beta-adrenoceptor antagonist (β-blocker) treatment reduces the incidence of reversion to AF in patients, possibly via an adaptive myocardial response.
Kane, K.A., Norrie, J., Rankin, A.C., Russell, J.A., Workman, A.J.   +4 more
core   +1 more source

Development of an international standard set of outcome measures for patients with atrial fibrillation: a report of the International Consortium for Health Outcomes Measurement (ICHOM) atrial fibrillation working group. [PDF]

, 2020
AIMS: As health systems around the world increasingly look to measure and improve the value of care that they provide to patients, being able to measure the outcomes that matter most to patients is vital.
Arbelo, E, Banerjee, A, Bollmann, A, Caffrey-Armstrong, B, Camm, AJ, Cehic, DA, Collins, M, Corbalan, R, Dandamudi, G, Das-Gupta, Z, Dorairaj, P, Fay, M, Goto, S, Granger, CB, Gyorgy, B, Healey, JS, Hendriks, JM, Hills, MT, Hobbs, FDR, Huisman, MV, Jobi-Odeneye, AO, Koplan, KE, Lane, DA, Lewis, WR, Lobban, T, McLeod, CJ, Moseley, S, Seligman, WH, Steinberg, BA, Timmis, A, Van Gelder, IC, Yutao, G   +31 more
core   +4 more sources

Efficacy and Safety of Dronedarone in Overweight and Obesity: Post Hoc Analysis of the ATHENA Trial

Journal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Introduction Obesity represents a prevalent condition with multiple comorbidities, including atrial fibrillation (AF). Dronedarone, an antiarrhythmic drug (AAD), has demonstrated efficacy in patients with paroxysmal/persistent AF and cardiovascular (CV) risk factors.
Mate Vamos, Anna Vagvolgyi, David S. McKindley, Stefan H. Hohnloser   +3 more
wiley   +1 more source

Electrocardiographic predictors of early recurrence of atrial fibrillation

Annals of Noninvasive Electrocardiology, 2021
Background Electrical cardioversion (ECV) is an effective method for restoring sinus rhythm after atrial fibrillation (AF). However, early recurrence of AF occurs in a significant number of patients after ECV.
Ji‐Hoon Choi, Hee‐Jin Kwon, Hye Ree Kim, Seung‐Jung Park, June Soo Kim, Young Keun On, Kyoung‐Min Park   +6 more
doaj   +1 more source

QTc Dynamics Following Cardioversion for Persistent Atrial Fibrillation

Frontiers in Cardiovascular Medicine, 2022
BackgroundCardioversion (CV) for atrial fibrillation (AF) is common. We aimed to assess changes in QTc over time following electrical CV (ECV) for persistent AF, and to compare the benefit of using continuous Holter monitoring vs.
Arwa Younis, Nofrat Nehoray, Michael Glikson, Christopher Bodurian, Eyal Nof, Nicola Luigi Bragazzi, Michael Berger, Wojciech Zareba, Ilan Goldenberg, Roy Beinart   +9 more
doaj   +1 more source

Impact of Emergent Physician Notifications from Mobile Cardiac Outpatient Telemetry on Patient Outcomes (The EP‐COT Trial)

Journal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Introduction Mobile ambulatory cardiac telemetry (MCOT) use has increased over time; however, data on the prevalence and the impact of emergent arrhythmia notifications with MCOT remains unclear. We sought to determine the prevalence and clinical impact of emergent arrhythmia events in patients undergoing MCOT monitoring.
David Lin, Sanchit Kumar, Khurram Butt, Jake Klewer, Mahesh Balakrishnan, Alvaro Altamirano, Aaron Vigdor, Andrea Schell, Purvee Parikh, C. J. Grigoriadis, Manish Wadhwa, Mathew D. Hutchinson   +11 more
wiley   +1 more source

The role of edoxaban in preventing thromboembolic complications in patients with atrial fibrillation

Атеротромбоз, 2020
Edoxaban is a selective direct factor Xa inhibitor. Edoxaban in a dose of 60 mg per day is an effective and safe option in the prevention of thromboembolic complications in patients with nonvalvular atrial fibrillation, including in combination therapy ...
O. O. Shakhmatova
doaj   +1 more source

Intermediate-Term Risk of Stroke Following Cardiac Procedures in a Nationally Representative Data Set. [PDF]

, 2017
BACKGROUND: Studies on stroke risk following cardiac procedures addressed only perioperative and long-term risk following limited higher-risk procedures, were poorly generalizable, and often failed to stratify by stroke type. We calculated stroke risk in
Dhamoon, Amit S., Dhamoon, Mandip S., Liang, John W., Stein, Laura, Thaler, Alison, Tuhrim, Stanley   +5 more
core   +2 more sources

Diazepam in cardioversion [PDF]

Canadian Anaesthetists’ Society Journal, 1971
Ce travail decrit nos experiences au cours de 161 cardioversions par courant direct, dont 76 ont ete pratiquees sous anesthesie au diazepam seul et 85 sous anesthesie par divers agents. Generalement le premier choc etait de 100 watts seconde, et les suivants, si besoin, allaient en s’accroissant a partir de 100 watts seconde. Dans le groupe du diazepam,
L N, Vinge, G M, Wyant, J F, Lopez
openaire   +2 more sources

Prospective Trial of Radiofrequency Catheter Ablation of High Dominant Frequencies After Pulmonary Vein Isolation in Non‐Paroxysmal Atrial Fibrillation (PAD‐AF Trial): A Multicenter, Randomized Clinical Trial

Journal of Cardiovascular Electrophysiology, EarlyView.
In persistent AF, adjunctive dominant frequency‐guided ablation after pulmonary vein isolation did not significantly improve outcomes. Limited overlap between high‐frequency sites and low‐voltage areas suggests functional–structural dissociation, while right atrial low‐voltage burden predicts recurrence.
Koji Kumagai, Tomoaki Hasegawa, Daisuke Kutsuzawa, Yuichi Hanaki, Masahide Harada, Hitoshi Hachiya, Yuhi Hasebe, Kazuki Noda, Minoru Yambe, Hirohito Metoki, Kazutaka Aonuma   +10 more
wiley   +1 more source